Structured Reporting

Data Mapping

Structured Reporting is currently being investigated by the NHS England Genomics Unit. The following page outlines the initial data mapping to FHIR, using the ACGS guidelines as the business requirements, which imply an underlying reporting data model. This will be further refined as the NHS England Genomics Unit starts a focused reporting business analysis activity.

ACGS Section ACGS Guidance Conformance Requirement FHIR Element Notes
Report Format - General format Interpretation and implications SHALL DiagnosticReport.conclusionCode and DiagnosticReport.result Using diagnostic and therapeutic implication slices
Report Format - General format Overall result and conclusion SHALL DiagnosticReport.conclusion TBC Coding scheme used for conclusion codes
Report Format - General format Report only goes to authorised recipients SHALL Composition.extension:informationRecipient MAY also use subscriptions via DiagnosticReport.basedOn(ServiceRequest.requester)
Report Format - General format Supporting information in appendices with patient identifier SHOULD DiagnosticReport.extension:supporting-info Each resource would additionally reference the patient
Report Format - General format Background/context as may be seen by patient or other HCP MAY DiagnosticReport.basedOn or DiagnosticReport.extension:supporting-info Used basedOn where context is captured in a ServiceRequest
Report Format - Recipients of reports - Name, contact details (or unique identifier), referral unit for requesting clinician and additional copy recipients SHALL ServiceRequest.requester(PractitionerRole) Multiple elements in PractitionerRole including identifier, practitioner, organization, telecom
Report Format - Recipients of reports Comply with laws around archiving SHALL N/A Part of surrounding governance, not payload
Report Format - Recipients of reports Copy to requesting lab for out of region tests SHOULD Composition.extension:informationRecipient
Report Format - Recipients of reports Direct patient reporting not recommended SHOULD NOT DiagnosticReport.meta(security=NOPAT)
Report Format - Laboratory identification Issuing lab and contact details SHALL DiagnosticReport.performer(PractitionerRole/Organization TBC)/Composition.author
Report Format - Laboratory identification Title and issue date SHOULD Composition.title and DiagnosticReport.issued
Report Format - Laboratory identification Accreditation status of lab test (in compliance with lab accreditation status) SHOULD RegulatedAuthorization There is also a proposed extension for LabAccreditationStatus for procedure being develoepd by HL7 EU
Report Format - Patient and Sample Identification Patient identified by name and DoB SHALL DiagnosticReport.subject(Patient) This information would likely be included in the Patient name/birthDate. In FHIR, for NHS patients, this would be in the PDS record only
Report Format - Patient and Sample Identification - Unique lab number/nhs number SHALL DiagnosticReport.subject.identifier
Report Format - Patient and Sample Identification Prenatal result from fetus, not mother, clearly indicated if multiple samples from one pregnancy, multiple fetuses etc. SHALL Observation.subject Could also be obtained from the Observation.specimen.subject. TBC Pregnancy identifier is still under investigation
Report Format - Patient and Sample Identification For infant samples, include DoB and hospital/nhs number (future siblings will have the same, Baby FamilyName name) SHALL Specimen.subject(Patient) NHS registered patients expected to have NHS Number, birthDate on PDS record
Report Format - Patient and Sample Identification For infant samples, may also include phenotypic gender or genetic sex MAY Specimen.subject(Patient) NHS registered patients expected to have gender on PDS record (sexAtBirth extension usage TBC). Genetic sex MAY be represented as an Observation
Report Format - Patient and Sample Identification Where clinically relevant, sex or gender SHOULD Patient.extension:birthSex and Patient.gender For sex at birth, currently QuestionnaireResponse.item(linkId=1345193002).answer is being used as an interim measure for PDS registered patients.
Report Format - Patient and Sample Identification Stand-alone report for each patient SHOULD DiagnosticReport.subject Separate DiagnosticReport for each subject
Report Format - Patient and Sample Identification Limit family information e.g. family members, unless pertinent SHOULD NOT RelatedPerson RelatedPersons, FamilyMemberHistory etc. to reduce patient identifiable information included wherever possible
Report Format - Results and Interpretation ACMG guidelines used for Sequence variant classification and interpretation SHALL TBC Data requirements not yet investigated
Report Format - Results and Interpretation - Correct and appropriate nomenclature Nomenclature for variants to use ISCN or HGVS SHALL DiagnosticReport.result:variant(Observation) Observation.component:genomic-hgvs/cytogenetic-nomenclature coding system to use the CodeSystem for HGVS or ISCN
Report Format - Results and Interpretation - Correct and appropriate nomenclature - If the test is FISH, ISCN not mandatory, results described in both headline summary and text instead SHALL Observation.component.code.text
Report Format - Results and Interpretation - Correct and appropriate nomenclature - If results include repeat expansions, HGVS not mandatory, results presented in words SHALL Observation.component.code.text
Report Format - Results and Interpretation - Correct and appropriate nomenclature - Key including size ranges for normal, intermediate/premutation, affected, with reference SHALL Observation.referenceRange and Observation.extension:workflow-relatedArtifact
Report Format - Results and Interpretation - Correct and appropriate nomenclature If reporting nucleotide coordinates, codon numbering, protein amino acid numbering used, the gene reference sequence/genome build is required SHALL Observation.component:coordinate-system
Report Format - Results and Interpretation - Correct and appropriate nomenclature - If genomic coordinates used, genome build required SHALL Observation.component:reference-sequence-assembly
Report Format - Results and Interpretation - Correct and appropriate nomenclature - If gene specific coordinates used, reference sequence for gene required SHALL Observation.component:genomic-ref-seq Only public approved/finalised Locus Reference Genomic (LRG) Sequences can be used, otherwise NCBI Reference Sequence is required
Report Format - Results and Interpretation - Correct and appropriate nomenclature - If coding nucleotide numbering used, transcript number required SHALL Observation.component:representative-transcript-ref-seq
Report Format - Results and Interpretation - Correct and appropriate nomenclature - Additional notes to clarify numbering as necessary MAY Observation.component.code.text/Observation.note
Report Format - Results and Interpretation - Correct and appropriate nomenclature If exon numbering included, reference/explanation of numbering required SHALL Observation.component:coordinate-system and Observation.extension:workflow-relatedArtifact LRG exon preferred including a statement that exon numbering in accordance with LRG quoted (Observation.note), otherwise numbering referenced
Report Format - Results and Interpretation - Correct and appropriate nomenclature - For intragenic copy number variants (deletions/duplications of exons), recommended to describe in words SHOULD TBC Observation.component:coding-change-type/copy-number
Report Format - Results and Interpretation - Correct and appropriate nomenclature - CNV description acceptable as ISCN/HGVS MAY TBC Observation.component:genomic-hgvs/cytogenetic-nomenclature
Report Format - Results and Interpretation - Correct and appropriate nomenclature If other nomenclature is used, state system and ISCN/HGVS equivalents SHOULD Observation.component.coding.system and Observation.component:genomic-hgvs/cytogenetic-nomenclature.coding.system = HGVS/ISCN
Report Format - Results and Interpretation - Restate the clinical question being asked Restate clinical question (either referral or in report) SHALL DiagnosticReport.basedOn
Report Format - Results and Interpretation - Restate the clinical question being asked - Additional information from referral which has bearing on clinical question SHALL DiagnosticReport.extension:supporting-info
Report Format - Results and Interpretation - Clinical interpretation Restate information used for interpretation SHALL DiagnosticReport.extension:supporting-info/Observation.basedOn/derivedFrom
Report Format - Results and Interpretation - Clinical interpretation - Relationship between patient and index where family history exists MAY RelatedPerson/FamilyMemberHistory
Report Format - Results and Interpretation - Clinical interpretation - Ethnic background MAY Patient.extension:ethnicCategory/QuestionnaireResponse.item(linkId=364699009).answer QuestionnaireResponse used as an interim measure for collecting ethnicity for PDS registered patients
Report Format - Results and Interpretation - Clinical interpretation - Lab investigations MAY Procedure/Observation For referencing genomic analyses use the GenomicStudyAnalysis profile
Report Format - Results and Interpretation - Clinical interpretation - Suspicious clinical picture MAY ServiceRequest.supportingInfo(Media)
Report Format - Results and Interpretation - Clinical interpretation Guidance from latest guidelines for interpretation SHALL DiagnosticReport.extension:workflow-relatedArtifact
Report Format - Results and Interpretation - Clinical interpretation Where 2 (likely)pathogenic variants detected in a proband, and are unclear whether cis or trans, text should include ‘assuming these variants are inherited in trans, the result is consistent with a genetic diagnosis of disorder X’ SHOULD Observation.note Text likely in Observation.note unless in unstructured report text only
Report Format - Results and Interpretation - Clinical interpretation Positive/negative for variant not recommended, must be defined if used SHOULD NOT Observation.valueCodeableConcept Concepts used should match those used by the HL7 Genomics Reporting Implementation Guide, which includes definitions of terms
Report Format - Results and Interpretation - Clinical interpretation Term 'carrier' only used for autosomal/x-linked recessive disorder/incomplete penetrance SHOULD TBC Recording of carrier status to be investigated
Report Format - Results and Interpretation - Clinical interpretation - Autosomal recessive disorders For recessive disorders with pathogenic variants, text to state ‘this patient is at least a carrier' SHOULD Observation.note
Report Format - Results and Interpretation - Clinical interpretation - Autosomal recessive disorders For 2 pathogenic variants in a child, confirmatory carrier testing of parents recommended before prenatal diagnosis SHOULD DiagnosticReport.extension:recommended-action Referencing a Task recommending a confirmatory request (unless directly raised as part of the order management service interactions)
Report Format - Results and Interpretation - Clinical interpretation - Autosomal recessive disorders State ‘these results support the clinical diagnosis’ MAY Observation.derivedFrom DiagnosticImplication observation referencing lower level findings such as variant
Report Format - Results and Interpretation - Clinical interpretation - X-linked disorders Offer/exclude prenatal testing if report on pregnancy MAY DiagnosticReport.extension:recommended-action
Report Format - Results and Interpretation - Clinical interpretation - Reporting variants of uncertain significance (VUS) ACGS guidelines on variant classification to be used for VUS SHALL TBC Data requirements not yet investigated
Report Format - Results and Interpretation - Clinical interpretation - Reporting variants of uncertain significance (VUS) - State if no clear diagnosis can be made SHALL DiagnosticReport.conclusion
Report Format - Results and Interpretation - Clinical interpretation - Acquired genetic abnormalities in leukaemias and solid tumours Link report to assessment by haematologist of proportion of neoplastic cells in sample (if no link, report qualified to point out malignant clone not represented, i.e. possible false negative) SHOULD DiagnosticReport.supporting-info or Observation.interpretation Reference to Observation following neoplastic cell example
Report Format - Results and Interpretation - Clinical interpretation - Acquired genetic abnormalities in leukaemias and solid tumours Abnormal results classified according to WHO SHOULD DiagnosticReport.conclusionCode.coding.system=WHO
Report Format - Results and Interpretation - Clinical interpretation - Acquired genetic abnormalities in leukaemias and solid tumours Cite studies linking variant to prognosis MAY Observation.extension:workflow-relatedArtifact
Report Format - Results and Interpretation - Family studies If family results are complex, include pedigree (drawn using Oxford Desk Reference, only include those relevant to interpretation) SHOULD DiagnosticReport.media or DiagnosticReport.extension:supporting-info Dependent on whether the pedigree is an image or structured (FamilyMemberHistory)
Report Format - Results and Interpretation - Family studies - Include date of issue and key SHOULD Media.issued/FamilyMemberHistory.date
Report Format - Results and Interpretation - Family studies - Consider confidentiality SHOULD Media.subject = Group/FamilyMemberHistory.identifier No patient identifiable data required in the reference to the related person
Report Format - Results and Interpretation - Family studies Include pedigree number SHOULD Group.identifier
Report Format - Results and Interpretation - Family studies Complex family data in tables MAY TBC DiagnosticReport.media
Report Format - Results and Interpretation - Reporting carrier status in prenatal samples For prenatal x-linked/autosomal recessive, genotype and carrier status of fetus SHOULD DiagnosticReport.result:genotype
Report Format - Results and Interpretation - Assessment/calculation of risk/recurrence State Genetic carrier risk, bayesian calculation SHOULD DiagnosticReport.extension:genomic-risk-assessment
Report Format - Results and Interpretation - Assessment/calculation of risk/recurrence Comment on risk of expansion for diseases which show anticipation SHOULD DiagnosticReport.result:diagnostic-implication Likely via Observation.note
Report Format - Results and Interpretation - Assessment/calculation of risk/recurrence State implications on family members SHOULD DiagnosticReport.result:diagnostic-implication May also be captured in report text only or in DiagnosticReport.conclusion
Report Format - Results and Interpretation - A clear written description of the genetic abnormality Description of genetic abnormality and interpretation SHALL DiagnosticReport.result:molecular-consequence/genotype and DiagnosticReport.conclusion
Report Format - Results and Interpretation - A clear written description of the genetic abnormality - Avoid the term abnormal where carrier has constitutional balanced rearrangement SHALL N/A Guidance applicable to text/code used
Report Format - Results and Interpretation - The name of any associated syndrome/disease/prognosis Appropriate to include names of associated syndrome, disease, prognosis where relevant MAY DiagnosticReport.result:diagnosticImplication
Report Format - Results and Interpretation - The basis of the test Test methodology and technical details relevant to interpretation SHALL Procedure(GenomicStudyAnalysis).extension:method-type Technical details can be found elsewhere within the GenomicStudyAnalysis Procedure resource
Report Format - Results and Interpretation - The basis of the test Technical sensitivity and practical resolution SHALL Procedure(GenomicStudyAnalysis).extension:metrics
Report Format - Results and Interpretation - The basis of the test - Which information on referral influenced decision on sensitivity, including references SHALL DiagnosticReport.extension:supporting-info/workflow-relatedArtifact Ideally the extensions would be placed on the Procedure resource as they impact the methodology used, but Procedure is not an allowed context for workflow-relatedArtifact
Report Format - Results and Interpretation - The basis of the test State if testing incomplete or minimum quality not achieved SHALL DiagnosticReport.conclusionCode TBC Codes to be determined
Report Format - Results and Interpretation - The basis of the test Manufacturer, kit number, version of commercial kit, probes, software recorded (not necessarily on report) MAY Procedure(GenomicStudyAnalysis).extension:device
Report Format - Results and Interpretation - Reporting of results from sequencing Follow ACGS guidelines for targeted next gen seq, for WES/WGS SHALL TBC Data requirements not yet investigated
Report Format - Results and Interpretation - Referral for genetic counselling Recommend referral for patient and family to genetic counselling for cases from non-genetic specialty SHOULD DiagnosticReport.extension:recommended-action
Report Format - Results and Interpretation - Referral for genetic counselling - State support available from clinical genetics, for benefit of other HCPs SHOULD N/A Likely part of report text only
Report Format - Results and Interpretation - Referral for genetic counselling - Offer referral to clinical genetics for testing offered to family SHOULD DiagnosticReport.extension:recommended-action Task.for referencing related person
Report Format - Results and Interpretation - Further tests and/or information Indicate further tests to improve accuracy/scope MAY DiagnosticReport.extension:recommended-action
Report Format - Results and Interpretation - Further tests and/or information - Suggest alternative labs where these are not offered by the reporting lab MAY N/A Would likely be informed by DGTS routing
Report Format - Results and Interpretation - Further tests and/or information - Can state no further testing planned MAY N/A Unstructured text only
Report Format - Results and Interpretation - Further tests and/or information - Contact for lab to discuss results MAY DiagnosticReport.resultsInterpreter
Report Format - Results and Interpretation - No testing performed Requests for sample storage (where testing is not performed) must have report SHALL DiagnosticReport/Composition
Report Format - Results and Interpretation - Reporting of results performed by another laboratory Validation of transcription/accuracy when re-reporting MAY N/A Not part of FHIR payload
Report Format - Results and Interpretation - Reporting of results requested by another laboratory The lab receiving samples for testing shall report directly to referring clinician (cc'ing referring lab) SHALL Composition.extension:informationRecipient
Report Format - Results and Interpretation - Reporting of results requested by another laboratory - Referring lab may also need to forward report MAY N/A The Genomic Order Management Service is intended to remove the need for forwarding reports
Report Format - Results and Interpretation - Integrated reporting Integrated reporting, i.e. multiple tests for one event in single report, encouranged SHOULD DiagnosticReport.extension:genomic-study Multiple tests recorded via GenomicStudy profile
Report Format - Results and Interpretation - Integrated reporting - Must have overarching interpretation for all results SHALL DiagnosticReport.conclusion
Authorisers of Reports Authoriser must have professional registration SHALL Composition.attester:validator Note that recording of professional registration in the FHIR payload is out of scope
Authorisers of Reports - Indicate report has been authorised but name/signature not required if stored on LIMS SHALL DiagnosticReport.status=final Reference to Practitioner not required
Authorisers of Reports - Competence - Competency may be on a category/template/test basis SHALL N/A Competencies outside scope of FHIR reporting
Interim/Preliminary Reports Final report issued to requester SHOULD Composition.extension:informationRecipient
Interim/Preliminary Reports May issue prelim report, must be marked as preliminary MAY DiagnosticReport.status=preliminary
Addendum/Revised Reports Addendum report stand-alone, identified as revision, reference to date and patient identity in original report SHOULD DiagnosticReport.status=amended Following Acknowledgement Framework approach for ammendments and corrections
Addendum/Revised Reports - Requester should be made aware SHOULD N/A MNS notification
Addendum/Revised Reports - Must state whether report is a replacement or supersedes original (where it replaces, the original should be destroyed) SHOULD DiagnosticReport.status=amended/DiagnosticReport.extension:diagnosticReport-replaces
Addendum/Revised Reports - Retained by lab in cumulative reports SHOULD N/A Business process outside payload
Disclaimers No disclaimers about samples, relationships or long-term DNA storage required MAY NOT N/A Only appropriate where errors are due to factors outside of lab control
Disclaimers - Caution when reports are based on DNA or reports from other labs MAY NOT DiagnosticReport.extension:supporting-info(DiagnosticReport) Could be recorded via DiagnosticReport.performer. The caution is likely free text only
References Within Reports References included when key to interpretation SHOULD DiagnosticReport.extension:workflow-relatedArtifact
References Within Reports - Necessary when data is new/not widely accepted, e.g. patient leaflets SHALL DiagnosticReport.extension:workflow-relatedArtifact
References Within Reports - State which used when conflicting publications exist SHOULD N/A Only references which are used are expected to be referenced within the DiagnosticReport
References Within Reports - Readable referencing format SHOULD RelatedArtifact.citation Using recognised referencing format
References Within Reports - Reflect best practice guidelines SHOULD N/A Part of lab standard operating procedures
Reporting Time Targets Maintain adequate reporting times SHOULD DiagnosticReport.issued Turn around times are expected to be the difference between the date a sample is received with all the data or when the investigation is activated, if on stored sample, and when results are available in authorised state (not necessarily sent out by lab)
Validation of Results from Research Laboratories or Projects Validate results from non-accredited labs in accredited lab before use and review research interpretation SHOULD N/A Part of lab workflow
Archiving and Storage Follow information govenance, data protection and storage guidance, ISO 15189, for records and specimens SHOULD N/A Part of data retention and privacy protection implementation